Navigation Links
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
Date:6/8/2009

EXTON, Pa., June 8 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced the appointment of Frank Baldino, Jr., Ph.D. to its board of directors.

Dr. Baldino brings several decades of pharmaceutical and health care industry experience and leadership to ViroPharma. He is the chief executive officer and chairman of the board of directors of Cephalon Inc., an international biopharmaceutical company in Chester County, Pennsylvania. Dr. Baldino founded Cephalon in 1987 and has served as chief executive officer and director since its inception.

Prior to joining Cephalon, he served as senior research biologist in the medical products department at E.I. duPont de Nemours & Company, where he was responsible for developing research strategies for identifying novel neuropharmaceutical agents. He has authored more than 100 publications in peer-reviewed journals such as Nature, Journal of Neuroscience Research, and Brain Research. Dr. Baldino received his Ph.D. in pharmacology from Temple University.

Dr. Baldino previously served as a member of ViroPharma's board of directors from 1996 to 2006.

"We are extremely pleased to welcome Frank Baldino, one of the most successful biopharmaceutical entrepreneurs, back to our board of directors," commented Vincent Milano, president and chief executive officer of ViroPharma. "For over a decade, Frank was an extraordinarily valuable member of our board, and we benefited significantly from his guidance and his experience. He brings to ViroPharma a wealth of experience in virtually any issue that a growing pharmaceutical company might encounter, and we are thrilled to welcome him back to our board."

"I am excited to have the opportunity to serve again on the board of directors of
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
2. ViroPharma to Present at Two May Healthcare Conferences
3. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
4. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
5. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
6. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
7. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
8. ViroPharma Provides Update on Vancocin(R)
9. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
10. ViroPharma To Present At The 20th Annual Piper Jaffray Healthcare Conference
11. ViroPharma to Discuss Commercialization and Launch of Cinryze(TM) on November 5, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... AngelWeddingDress is now providing worldwide clients ... collections ”. When it comes to buying summer wedding ... with the unlimited stock of beautiful wedding gowns. Recently, ... wonderful summer wedding gowns. , The company’s current ... keep pace with the newest fashion trends. The top ...
(Date:7/11/2014)... OR (PRWEB) July 11, 2014 Recent research ... life, health, the atmosphere, and how water affects human bodies. ... Water, Gerald Pollack, during an interview on the Sharon Kleyne ... , Gerald Pollack, PhD, is a Professor ... is The Fourth Phase of Water (Ebner & Sons, 2013). ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 American Farmer ... RFD-TV, next Tuesday, July 15, 2014, at 8:30 am ... line of proprietary products, which are designed and formulated ... Audiences will learn how these products help the crop ... in which it is grown. , The show also ...
(Date:7/11/2014)... Cancer researchers in Slovenia say genetic variations called ... patients respond to treatment with pemetrexed (Alimta), the most ... full story. Click here to read the new ... Ljubljana and the Ljubljana Institute of Oncology tested ... polymorphisms. They found that patients with genetic variations in ...
(Date:7/11/2014)... Alliance Labs announced that they will be ... Begley Jr, airing later this year 2014, via Discovery ... episode, Innovations will explore DocuSol® Kids, a mini-enema containing ... glycol base designed to give adolescents general constipation relief. ... a hyperosmotic laxative by drawing water into the bowel ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Will Continuously Unveil More Summer Wedding Dresses for Loyal Clients 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 3Health News:New Episode of American Farmer Featuring Sunbelt, UniSouth Genetics, and Michigan Milk Producers Association Airing on RFD-TV 2Health News:New Research Finds Genetic Variables Impact Chemotherapy Response, According to Surviving Mesothelioma 2Health News:Alliance Labs & DocuSol® to be Featured in Upcoming Episode of Innovations 2
... at settling a long-standing question among doctors has found that ... patients avoid recurrent strokes. Many doctors suspected that Warfarin was ... both views, showing the two drugs are equals in both ... and blood clots are involved in the final stages of ...
... immunodeficiency virus is a retrovirus that binds to receptors found ... a cell, the virus is internalized, copied into DNA, then ... of the host DNA. In many cases, the inserted viral ... more years. AIDS or Acquired Immune Deficiency Syndrome is a ...
... uterus, the more likely she is to have a miscarriage, ... Journal of Medicine details the most precise information the timing ... its success or failure. ,Fertilised eggs can attach themselves ... 12 days after ovulation, the researchers from the National Institute ...
... too soon is more likely to produce stressed-out toddlers ... targets for three to five-year olds could lead to ... than achieve accelerated learning, says the report. ... early start to their schooling and may revert to ...
... risks,say the researchers.Traditional student digs with mouldy and damp ... ,A study of over 20,000 Finnish students found that ... of asthma, but left residents with a greater chance ... damp houses were found to need more antibiotics than ...
... a virus is possibly resposible for infertility.The virus is ... of testicular tissue taken from men whose semen was ... more frequently than in those with normal semen. ... Heidelberg, which conducted the research, said the virus should ...
Cached Medicine News:Health News:More about HIV 2Health News:More about HIV 3
(Date:7/10/2014)...  Major advances in radiation therapy and radiosurgery ... in a three-day Oncology Summit taking place in ...  Renowned national and international cancer experts from seven countries ... knowledge on modern technologies making treatment for cancer ... The Summit will address a wide spectrum ...
(Date:7/10/2014)... , 11. Juli 2014  Dilon ... für die molekulare Bildgebung, einschließlich molekularer ... die CE-Zulassung für sein Navigator ® ... Dilon das Produkt jetzt europaweit vertreiben. ... Großteil der europäischen Länder ausgedehnt und ...
(Date:7/10/2014)... U.S. Department of Health and Human Services (HHS) has ... Medical Center Seidman Cancer Center totaling $4.7 million to ... for patients with complex cancer. Titled ... model developed at UH to enhance care for adult ... need for high health care utilization.  ...
Breaking Medicine Technology:Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4
... IRIDEX Corporation (Nasdaq: IRIX ) today reported ... Revenues were $10.8 million, gross margins were 45.4% ... of 2011 compared to guidance of $10 million, 45%, and ... the third quarter of 2011 and 7% in the nine ...
... an increased need by customers for support and education ... chain-wide effort to increase its pharmacy expertise in the ... diabetes specialists, announced Effie Steele, clinical services manager for ... community pharmacist is an important first line of defense ...
Cached Medicine Technology:IRIDEX Reports 2011 Third Quarter and Nine-Month Results 2IRIDEX Reports 2011 Third Quarter and Nine-Month Results 3IRIDEX Reports 2011 Third Quarter and Nine-Month Results 4IRIDEX Reports 2011 Third Quarter and Nine-Month Results 5Meijer Launches Diabetes Education Initiative in All 197 Pharmacies, Trains More Than 200 Pharmacists to Be Diabetes Specialists 2Meijer Launches Diabetes Education Initiative in All 197 Pharmacies, Trains More Than 200 Pharmacists to Be Diabetes Specialists 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: